Updated Jul 16, 2026
LAI GOLDMAN MYLA has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-09 | QTRX | Quanterix Corp | M — Option exercise | 8.1K | — | |
| 2026-05-06 | WST | WEST PHARMACEUTICAL SERVICES INC | A — Grant or award | 791 | $0.00 | |
| 2025-10-01 | QTRX | Quanterix Corp | A — Grant or award | 2.1K | $5.54 | $12K |
| 2025-07-08 | QTRX | Quanterix Corp | A — Grant or award | 24.5K | $0.00 | |
| 2025-07-08 | QTRX | Quanterix Corp | A — Grant or award | 2.9K | — | |
| 2025-07-08 | AKYA | Akoya Biosciences, Inc. | J — Other acquisition / disposition | 20.0K | — | |
| 2025-05-06 | WST | WEST PHARMACEUTICAL SERVICES INC | A — Grant or award | 1.1K | $0.00 |
LAI GOLDMAN MYLA is a corporate insider — currently tracked as Insider of Quanterix Corp (QTRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LAI GOLDMAN MYLA profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.